0000899243-21-007141.txt : 20210218 0000899243-21-007141.hdr.sgml : 20210218 20210218170913 ACCESSION NUMBER: 0000899243-21-007141 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210216 FILED AS OF DATE: 20210218 DATE AS OF CHANGE: 20210218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cassidy Sean A CENTRAL INDEX KEY: 0001421914 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38672 FILM NUMBER: 21650513 MAIL ADDRESS: STREET 1: 322 EAST MAIN STREET CITY: BRANFORD STATE: CT ZIP: 06405 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARVINAS, INC. CENTRAL INDEX KEY: 0001655759 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472566120 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 395 WINCHESTER AVE STREET 2: 5 SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 203-535-1456 MAIL ADDRESS: STREET 1: 395 WINCHESTER AVE STREET 2: 5 SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 FORMER COMPANY: FORMER CONFORMED NAME: ARVINAS INC. DATE OF NAME CHANGE: 20181001 FORMER COMPANY: FORMER CONFORMED NAME: ARVINAS HOLDING COMPANY, LLC DATE OF NAME CHANGE: 20151015 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-16 0 0001655759 ARVINAS, INC. ARVN 0001421914 Cassidy Sean A C/O ARVINAS, INC. 5 SCIENCE PARK, 395 WINCHESTER AVE. NEW HAVEN CT 06511 0 1 0 0 Chief Financial Officer Common Stock 2021-02-16 4 M 0 6815 16.00 A 161599 D Common Stock 2021-02-16 4 M 0 35144 16.00 A 196743 D Common Stock 2021-02-16 4 S 0 8158 77.5979 D 188585 D Common Stock 2021-02-16 4 S 0 19303 78.6125 D 169282 D Common Stock 2021-02-16 4 S 0 3958 79.3164 D 165324 D Common Stock 2021-02-16 4 S 0 396 80.2812 D 164928 D Common Stock 2021-02-16 4 S 0 2793 77.6207 D 162135 D Common Stock 2021-02-16 4 S 0 6160 78.6465 D 155975 D Common Stock 2021-02-16 4 S 0 1161 79.424 D 154814 D Common Stock 2021-02-16 4 S 0 30 80.4347 D 154784 D Stock Option (right to buy) 16.00 2021-02-16 4 M 0 6815 0.00 D 2028-09-25 Common Stock 6815 0 D Stock Option (right to buy) 16.00 2021-02-16 4 M 0 35144 0.00 D 2028-09-25 Common Stock 35144 46262 D The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.04 to $78.035, inclusive. The reporting person undertakes to provide to Arvinas, Inc., any security holder of Arvinas, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (10) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.04 to $79.03, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.04 to $79.91, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.04 to $80.74, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.05 to $78.04, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.09 to $79.07, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.10 to $79.91, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.42 to $80.86, inclusive. This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2017 and the remainder of the shares vested in equal monthly installments following January 1, 2017 through January 1, 2020. This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested on March 31, 2019, with the remainder of the shares vesting in equal monthly installments following March 31, 2019 through March 31, 2022. /s/ Matthew Batters, as attorney-in-fact for Sean Cassidy 2021-02-18